Drug intelligence / Profile preview

PSORI-CM01 + calcipotriol

Development stage
Unknown
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral, Topical
01

Overview

PSORI-CM01 + calcipotriol is a combination therapy for psoriasis vulgaris, consisting of oral administration of the Chinese herbal medicine formula PSORI-CM01 and topical application of calcipotriol. PSORI-CM01 is a traditional Chinese herbal formulation with reported antipsoriatic pharmacological activity, while calcipotriol is a synthetic vitamin D3 analogue used topically to treat plaque psoriasis. The combination has been studied in randomized controlled trials as an adjunctive treatment for moderate-to-severe psoriasis vulgaris, aiming to improve clinical outcomes such as reduction in Psoriasis Area Severity Index (PASI) scores and relapse rates compared to standard therapy alone[1][2][3]. Calcipotriol acts primarily by binding to the vitamin D receptor on keratinocytes and immune cells, modulating gene expression related to cell differentiation and proliferation[6][7]. The mechanism of action for PSORI-CM01 is less well defined but involves immunomodulatory effects attributed to its herbal components.

02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)MMP9 (Matrix metalloproteinase-9)NF-κBPTGS2 (Prostaglandin-Endoperoxide Synthase 2)STAT3 (Signal Transducer and Activator of Transcription 3)TNFA (Tumor necrosis factor alpha (soluble))TP53 (Cellular Tumor Antigen p53 R175H)VEGFA (Vascular endothelial growth factor A)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on PSORI-CM01 + calcipotriol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSORI-CM01 + calcipotriol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call